According to the report “Next Generation Sequencing Market” published by Market Data Forecast, the global market is projected to reach USD 10.69 Billion by 2020, at a CAGR of 21.6% from 2015 to 2020.

For full report refer at

Modern technologies assist in the sequencing of DNA and RNA much more quickly and cheaply than the Sanger sequencing and these have transformed the study of genomics and molecular biology. Next generation sequencing technologies have brought notable changes in the sequencing process by providing speed, flexibility and reducing the cost over many folds

Free sample for the report is available at

Advancements in pre-sequencing and NGS bioinformatics solutions, Rise in growth of personalized medicine and cloud computing, increasing incidences of infectious diseases, growth in global population, and chronic diseases such cancer are few factors driving the market growth. However management and storage of data is major factor hindering the growth of the market

Request customization at

The next generation sequencing market is segmented as:

1)By Product

2)By Technology
•targeted re-sequencing
•genome sequencing
•de novo sequencing
•exome sequencing
•ChIP-Seq and

3)By Application
•drug discovery,
•biomarker discovery,
•personalized medicine, and
•agriculture & animals research

4)By Geography
•North America
•Latin America
•Africa & Middle East

Inquire more about the report at

The market is dominated by Illumina, which accounted for the largest market share of approximately 70%. Other major players in the market include Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Life Technologies Corp. (Thermo Fischer Scientific), Macrogen Inc.,Partek Inc., Genomatix Software GmbH, Perkin Elmer inc.,GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd.,Pacific Biosciences, DNASTAR Inc., Knome Inc., Illumina Inc., and Qiagen N.V.

Buy now at